Labcorp Holdings Inc. (LH)
NYSE: LH · Real-Time Price · USD
259.81
-1.56 (-0.60%)
At close: Nov 18, 2025, 4:00 PM EST
259.81
0.00 (0.00%)
After-hours: Nov 18, 2025, 4:13 PM EST
Labcorp Holdings Market Cap
Labcorp Holdings has a market cap or net worth of $21.55 billion as of November 18, 2025. Its market cap has increased by 12.89% in one year.
Market Cap
21.55B
Enterprise Value
27.48B
1-Year Change
12.89%
Ranking
Category
Stock Price
$259.81
Market Cap Chart
Since December 1, 1998, Labcorp Holdings's market cap has increased from $164.50M to $21.55B, an increase of 13,002.74%. That is a compound annual growth rate of 19.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2025 | 21.67B | 12.97% |
| Dec 31, 2024 | 19.18B | -0.60% |
| Dec 29, 2023 | 19.30B | -7.51% |
| Dec 30, 2022 | 20.86B | -30.62% |
| Dec 31, 2021 | 30.07B | 51.67% |
| Dec 31, 2020 | 19.83B | 20.69% |
| Dec 31, 2019 | 16.43B | 28.84% |
| Dec 31, 2018 | 12.75B | -21.48% |
| Dec 29, 2017 | 16.24B | 22.80% |
| Dec 30, 2016 | 13.22B | 5.68% |
| Dec 31, 2015 | 12.51B | 37.23% |
| Dec 31, 2014 | 9.12B | 14.17% |
| Dec 31, 2013 | 7.99B | -3.87% |
| Dec 31, 2012 | 8.31B | -2.50% |
| Dec 30, 2011 | 8.52B | -4.72% |
| Dec 31, 2010 | 8.94B | 12.50% |
| Dec 31, 2009 | 7.95B | 14.26% |
| Dec 31, 2008 | 6.96B | -20.05% |
| Dec 31, 2007 | 8.70B | -5.56% |
| Dec 29, 2006 | 9.21B | 28.71% |
| Dec 30, 2005 | 7.16B | 3.86% |
| Dec 31, 2004 | 6.89B | 30.34% |
| Dec 31, 2003 | 5.29B | 53.92% |
| Dec 31, 2002 | 3.44B | -39.59% |
| Dec 31, 2001 | 5.69B | -7.07% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 918.02B |
| Johnson & Johnson | 472.05B |
| AbbVie | 410.67B |
| UnitedHealth Group | 291.55B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 230.63B |
| Abbott Laboratories | 227.08B |